Press Releases
WISE Completes Enrolment in Pivotal Clinical Study of Novel Neuro-Electrodes for Brain Monitoring
WISE Srl, a medical device company developing next-generation implantable leads for neuromonitoring, neuromodulation and brain-machine interfacing, has completed enrolment in the pivotal clinical study of...
Press Releases
PhoreMost enters multi-project drug discovery collaboration with Otsuka Pharmaceutical
PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a multi-project collaboration with Otsuka Pharmaceutical Co., the...
Press Releases
Bormioli pharma unveils at Pharmapack Europe new products and services
Bormioli Pharma, leading global producer in the pharma packaging market, will attend Pharmapack Europe, one of the leading European events dedicated to pharmaceutical packaging, drug...
Press Releases
Aptar Pharma’s Nasal Unidose Device Approved by US FDA for New Nasal Seizure Rescue Treatment
Aptar Pharma, a global leader in drug delivery systems, services and active packaging solutions, announced that its patented Unidose Liquid System is the device delivering...
Clinical Trials
Greenphire Expands ConneX Global Travel Solution to Further Support Clinical Trial Participation and Retention Worldwide
Greenphire, the global leader in financial software for clinical trials, announced that it has expanded its ConneX global travel solution to include additional in-market support...
Clinical Trials
VBI Vaccines Announces Second Pivotal Phase 3 Study of Sci-B-Vac Meets Primary and Secondary Endpoints
VBI Vaccines Inc. (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, reported top-line data from CONSTANT, the second pivotal Phase 3...
Clinical Trials
Novo Seeds Portfolio Company HepaRegeniX GmbH secures Series B Financing in excess of EUR 11 Million
Novo Seeds, the early stage investment and company creation team of Novo Holdings, announced that its portfolio company HepaRegeniX GmbH, a preclinical stage company developing...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.